For weight loss data, see GLP-1 weight loss
Important Safety Information Do not use AOD-9604 if you: Have a known allergy to growth hormone fragments or any component of the formulation Have been diagnosed with active cancer or have a history of malignancy (use only under medical supervision) Are pregnant or breastfeeding (safety data is lacking) Have severe uncontrolled diabetes or metabolic disorders without medical supervision Common side effects may include: Injection site reactions, mild headaches, temporary fatigue, or slight dizziness during initial use
Importantly, these studies have not established a clear dose-response relationship, and there is no consensus on a minimum effective dose for clinically meaningful GLP-1 stimulation
For patients who may need both medication and surgery, which one should we recommend first
And make sure you know before you go
By integrating and analyzing multi-omics data together, AI enables the discovery of novel biomarkers and new druggable targets, performs drug repurposing, and saves both cost and time with respect to conventional methods (306)